Occult insulinoma with treatment refractory, severe hypoglycaemia in multiple endocrine neoplasia type 1 syndrome; difficulties faced during diagnosis, localization and management; a case report
Open Access
- 16 March 2022
- journal article
- case report
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 22 (1) , 1-9
Abstract
Background: Multiple endocrine neoplasia type 1 (MEN 1) syndrome is a rare, complex genetic disorder characterized by increased predisposition to tumorigenesis in multiple endocrine and non-endocrine tissues. Diagnosis and management of MEN 1 syndrome is challenging due to its vast heterogeneity in clinical presentation. Case presentation: A 23-year-old female, previously diagnosed with Polycystic Ovarian Syndrome (PCOS) and pituitary microprolactinoma presented with drowsiness,confusion and profuse sweating developing over a period of one day. It was preceded by fluctuating, hallucinatory behavior for two weeks duration. There was recent increase in appetite with significant weight gain. There was no fever, seizures or symptoms suggestive of meningism. Her Body mass index(BMI) was 32 kg/m2.She had signs of hyperandrogenism. Multiple cutaneous collagenomas were noted on anterior chest and abdominal wall. Her Glasgow Coma Scale was 9/15. Pupils were sluggishly reactive to light. Tendon reflexes were exaggerated with up going planter reflexes. Moderate hepatomegaly was present. Rest of the clinical examination was normal. Laboratory evaluation confirmed endogenous hyperinsulinaemic hypoglycaemia suggestive of an insulinoma. Hypercalcemia with elevated parathyroid hormone level suggested a parathyroid adenoma. Presence of insulinoma, primary hyperparathyroidism and pituitary microadenoma, in 3rd decade of life with characteristic cutaneous tumours was suggestive of a clinical diagnosis of MEN 1 syndrome. Recurrent, severe hypoglycaemia complicated with hypoglycaemic encephalopathy refractory to continuous, parenteral glucose supplementation and optimal pharmacotherapy complicated the clinical course. Insulinoma was localized with selective arterial calcium stimulation test. Distal pancreatectomy and four gland parathyroidectomy was performed leading to resolution of symptoms. Conclusions: Renal calculi or characteristic cutaneous lesions might be the only forewarning clinical manifestations of an undiagnosed MEN 1 syndrome impending a life-threatening presentation. Comprehensive management of MEN 1 syndrome requires multi-disciplinary approach with advanced imaging modalities, advanced surgical procedures and long-term follow up due to its heterogeneous presentation and the varying severity depending on the disease phenotype.Keywords
This publication has 41 references indexed in Scilit:
- Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1–associated primary hyperparathyroidismJournal of Bone and Mineral Research, 2010
- Sporadic and MEN1-Related Primary Hyperparathyroidism: Differences in Clinical Expression and SeverityJournal of Bone and Mineral Research, 2009
- Embolization as an Alternative Treatment of Insulinoma in a Patient with Multiple Endocrine Neoplasia Type 1 SyndromeCardioVascular and Interventional Radiology, 2009
- The Role of Intra-Arterial Calcium Stimulation Test with Hepatic Venous Sampling (IACS) in the Management of Occult InsulinomasAnnals of Surgical Oncology, 2007
- Familial multiple endocrine neoplasia type I: the urologist is first on the sceneBJU International, 2005
- Selective Arterial Calcium Stimulation and Hepatic Venous Sampling in the Evaluation of Hyperinsulinemic Hypoglycemia: Potential and LimitationsJournal of Vascular and Interventional Radiology, 2004
- Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison SyndromeMedicine, 2004
- Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1Gastroenterology, 1999
- Functioning Insulinoma—Incidence, Recurrence, and Long-Term Survival of Patients: A 60-Year StudyMayo Clinic Proceedings, 1991
- Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I)The American Journal of Medicine, 1979